INCY
IncyteยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
INCY Profile
Incyte Corporation
A global biopharmaceutical company that develops small molecule drugs to treat cancer and inflammatory diseases
1801 Augustine Cut-Off, Wilmington, DE 19803
--
Incyte Corporation was incorporated in Delaware in 1991. The Company is a global biopharmaceutical company dedicated to the discovery, development and commercialization of proprietary therapies. The company focuses on two therapeutic areas defined by the indications of its approved drugs and the diseases in development of its clinical candidates. One therapeutic area is hematology/oncology, including myeloproliferative tumors (MPN), graft-versus-host disease (GVHD), solid tumors and hematological malignancies. Another therapeutic area is inflammation and autoimmunity (IAI), including its dermatology commercial franchise. The company is also entitled to milestones and royalties on molecules it discovers and licenses to third parties.
